|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | C07K 16/28 | |
| A61K 39/395 | |||
| A61K 38/17 | |||
| A61P 35/00 |
| (11) | Patento numeris | 3092006 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 15735468.9 |
| Europos patento paraiškos padavimo data | 2015-01-08 | |
| (97) | Europos patento paraiškos paskelbimo data | 2016-11-16 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2019-03-20 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/US2015/010650 |
| Data | 2015-01-08 |
| (87) | Numeris | WO 2015/105995 |
| Data | 2015-07-16 |
| (30) | Numeris | Data | Šalis |
| 201461925143 P | 2014-01-08 | US |
| (72) |
WEISKOPF, Kipp, Andrew, US
SAGE, Julien, US
WEISSMAN, Irving, L., US
|
| (73) |
The Board of Trustees of the Leland Stanford Junior University,
Office of the General Counsel Building 170, 3rd Floor, Main Quad P.O. Box 20386, Stanford, CA 94305-2038,
US
|
| (54) | TARGETED THERAPY FOR SMALL CELL LUNG CANCER |
| TARGETED THERAPY FOR SMALL CELL LUNG CANCER |